Your browser doesn't support javascript.
loading
Pharmacokinetics, metabolism, and excretion of [14C]axitinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in humans.
Smith, Bill J; Pithavala, Yazdi; Bu, Hai-Zhi; Kang, Ping; Hee, Brian; Deese, Alan J; Pool, William F; Klamerus, Karen J; Wu, Ellen Y; Dalvie, Deepak K.
Affiliation
  • Smith BJ; Pharmacokinetics, Dynamics and Metabolism (B.J.S., H.-Z.B., P.K., W.F.P., E.Y.W., D.K.D.), Pfizer Oncology-Clinical Pharmacology (Y.P., B.H., K.J.K.), and Pharmaceutical Sciences (A.J.D.), Pfizer Inc., Worldwide Research and Development, La Jolla Laboratories, San Diego, CA.
Drug Metab Dispos ; 42(5): 918-31, 2014 May.
Article in En | MEDLINE | ID: mdl-24608633
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Receptors, Vascular Endothelial Growth Factor / Protein Kinase Inhibitors / Imidazoles / Indazoles Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Drug Metab Dispos Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Receptors, Vascular Endothelial Growth Factor / Protein Kinase Inhibitors / Imidazoles / Indazoles Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Drug Metab Dispos Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: